ParkinsonV1, Main, Corpus, bibRecord, 002A90

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration

Identifieur interne : 002A90 ( Main/Corpus ); précédent : 002A89; suivant : 002A91

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration

Auteurs : Olga Corti ; Cornelia Hampe ; Hana Koutnikova ; Fre De Ric Darios ; Sandrine Jacquier ; Annick Prigent ; Jean-Charles Robinson ; Laurent Pradier ; Merle Ruberg ; Marc Mirande ; Etienne Hirsch ; Thomas Rooney ; Alain Fournier ; Alexis Brice

Source :

Human Molecular Genetics [ 0964-6906 ] ; 2003-06-15.

RBID : ISTEX:14FE1C249A46B8793718122C5118CC5E1322F317

Abstract

Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. Mutations in the parkin gene, which encodes an E3 ubiquitin–protein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.

Url:

https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/fulltext/pdf

DOI: 10.1093/hmg/ddg159

Links to Exploration step

ISTEX:14FE1C249A46B8793718122C5118CC5E1322F317

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
<author><name sortKey="Corti, Olga" sort="Corti, Olga" uniqKey="Corti O" first="Olga" last="Corti">Olga Corti</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Hampe, Cornelia" sort="Hampe, Cornelia" uniqKey="Hampe C" first="Cornelia" last="Hampe">Cornelia Hampe</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Koutnikova, Hana" sort="Koutnikova, Hana" uniqKey="Koutnikova H" first="Hana" last="Koutnikova">Hana Koutnikova</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Darios, Fre De Ric" sort="Darios, Fre De Ric" uniqKey="Darios F" first="Fre De Ric" last="Darios">Fre De Ric Darios</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Jacquier, Sandrine" sort="Jacquier, Sandrine" uniqKey="Jacquier S" first="Sandrine" last="Jacquier">Sandrine Jacquier</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Prigent, Annick" sort="Prigent, Annick" uniqKey="Prigent A" first="Annick" last="Prigent">Annick Prigent</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Robinson, Jean Charles" sort="Robinson, Jean Charles" uniqKey="Robinson J" first="Jean-Charles" last="Robinson">Jean-Charles Robinson</name>
<affiliation><mods:affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pradier, Laurent" sort="Pradier, Laurent" uniqKey="Pradier L" first="Laurent" last="Pradier">Laurent Pradier</name>
<affiliation><mods:affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mirande, Marc" sort="Mirande, Marc" uniqKey="Mirande M" first="Marc" last="Mirande">Marc Mirande</name>
<affiliation><mods:affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Hirsch, Etienne" sort="Hirsch, Etienne" uniqKey="Hirsch E" first="Etienne" last="Hirsch">Etienne Hirsch</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rooney, Thomas" sort="Rooney, Thomas" uniqKey="Rooney T" first="Thomas" last="Rooney">Thomas Rooney</name>
<affiliation><mods:affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Fournier, Alain" sort="Fournier, Alain" uniqKey="Fournier A" first="Alain" last="Fournier">Alain Fournier</name>
<affiliation><mods:affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:14FE1C249A46B8793718122C5118CC5E1322F317</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1093/hmg/ddg159</idno>
<idno type="url">https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002A90</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
<author><name sortKey="Corti, Olga" sort="Corti, Olga" uniqKey="Corti O" first="Olga" last="Corti">Olga Corti</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Hampe, Cornelia" sort="Hampe, Cornelia" uniqKey="Hampe C" first="Cornelia" last="Hampe">Cornelia Hampe</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Koutnikova, Hana" sort="Koutnikova, Hana" uniqKey="Koutnikova H" first="Hana" last="Koutnikova">Hana Koutnikova</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Darios, Fre De Ric" sort="Darios, Fre De Ric" uniqKey="Darios F" first="Fre De Ric" last="Darios">Fre De Ric Darios</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Jacquier, Sandrine" sort="Jacquier, Sandrine" uniqKey="Jacquier S" first="Sandrine" last="Jacquier">Sandrine Jacquier</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Prigent, Annick" sort="Prigent, Annick" uniqKey="Prigent A" first="Annick" last="Prigent">Annick Prigent</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Robinson, Jean Charles" sort="Robinson, Jean Charles" uniqKey="Robinson J" first="Jean-Charles" last="Robinson">Jean-Charles Robinson</name>
<affiliation><mods:affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pradier, Laurent" sort="Pradier, Laurent" uniqKey="Pradier L" first="Laurent" last="Pradier">Laurent Pradier</name>
<affiliation><mods:affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mirande, Marc" sort="Mirande, Marc" uniqKey="Mirande M" first="Marc" last="Mirande">Marc Mirande</name>
<affiliation><mods:affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Hirsch, Etienne" sort="Hirsch, Etienne" uniqKey="Hirsch E" first="Etienne" last="Hirsch">Etienne Hirsch</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rooney, Thomas" sort="Rooney, Thomas" uniqKey="Rooney T" first="Thomas" last="Rooney">Thomas Rooney</name>
<affiliation><mods:affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Fournier, Alain" sort="Fournier, Alain" uniqKey="Fournier A" first="Alain" last="Fournier">Alain Fournier</name>
<affiliation><mods:affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation><mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Human Molecular Genetics</title>
<title level="j" type="abbrev">Hum. Mol. Genet.</title>
<idno type="ISSN">0964-6906</idno>
<idno type="eISSN">1460-2083</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="2003-06-15">2003-06-15</date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1427">1427</biblScope>
<biblScope unit="page" to="1437">1437</biblScope>
</imprint>
<idno type="ISSN">0964-6906</idno>
</series>
<idno type="istex">14FE1C249A46B8793718122C5118CC5E1322F317</idno>
<idno type="DOI">10.1093/hmg/ddg159</idno>
<idno type="local">ddg159</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0964-6906</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. Mutations in the parkin gene, which encodes an E3 ubiquitin–protein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.</div>
</front>
</TEI>
<istex><corpusName>oup</corpusName>
<author><json:item><name>Olga Corti</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Cornelia Hampe</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Hana Koutnikova</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Frédéric Darios</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Sandrine Jacquier</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Annick Prigent</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Jean-Charles Robinson</name>
<affiliations><json:string>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</json:string>
</affiliations>
</json:item>
<json:item><name>Laurent Pradier</name>
<affiliations><json:string>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</json:string>
</affiliations>
</json:item>
<json:item><name>Merle Ruberg</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Marc Mirande</name>
<affiliations><json:string>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</json:string>
</affiliations>
</json:item>
<json:item><name>Etienne Hirsch</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
<json:item><name>Thomas Rooney</name>
<affiliations><json:string>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</json:string>
</affiliations>
</json:item>
<json:item><name>Alain Fournier</name>
<affiliations><json:string>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</json:string>
</affiliations>
</json:item>
<json:item><name>Alexis Brice</name>
<affiliations><json:string>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Article</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<abstract>Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. Mutations in the parkin gene, which encodes an E3 ubiquitin–protein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.</abstract>
<qualityIndicators><score>7.976</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>610 x 795 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<keywordCount>1</keywordCount>
<abstractCharCount>1776</abstractCharCount>
<pdfWordCount>6748</pdfWordCount>
<pdfCharCount>45357</pdfCharCount>
<pdfPageCount>11</pdfPageCount>
<abstractWordCount>248</abstractWordCount>
</qualityIndicators>
<title>The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
<genre><json:string>research-article</json:string>
</genre>
<host><volume>12</volume>
<pages><last>1437</last>
<first>1427</first>
</pages>
<issn><json:string>0964-6906</json:string>
</issn>
<issue>12</issue>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<eissn><json:string>1460-2083</json:string>
</eissn>
<title>Human Molecular Genetics</title>
</host>
<categories><wos><json:string>BIOCHEMISTRY & MOLECULAR BIOLOGY</json:string>
<json:string>GENETICS & HEREDITY</json:string>
</wos>
</categories>
<publicationDate>2003</publicationDate>
<copyrightDate>2003</copyrightDate>
<doi><json:string>10.1093/hmg/ddg159</json:string>
</doi>
<id>14FE1C249A46B8793718122C5118CC5E1322F317</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
<respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Oxford University Press</publisher>
<availability><p>OUP</p>
</availability>
<date>2003</date>
</publicationStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
<author><persName><forename type="first">Olga</forename>
<surname>Corti</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Cornelia</forename>
<surname>Hampe</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Hana</forename>
<surname>Koutnikova</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Frédéric</forename>
<surname>Darios</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Sandrine</forename>
<surname>Jacquier</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Annick</forename>
<surname>Prigent</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Jean-Charles</forename>
<surname>Robinson</surname>
</persName>
<affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</affiliation>
</author>
<author><persName><forename type="first">Laurent</forename>
<surname>Pradier</surname>
</persName>
<affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</affiliation>
</author>
<author><persName><forename type="first">Merle</forename>
<surname>Ruberg</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Marc</forename>
<surname>Mirande</surname>
</persName>
<affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</affiliation>
</author>
<author><persName><forename type="first">Etienne</forename>
<surname>Hirsch</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
<author><persName><forename type="first">Thomas</forename>
<surname>Rooney</surname>
</persName>
<affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</affiliation>
</author>
<author><persName><forename type="first">Alain</forename>
<surname>Fournier</surname>
</persName>
<affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</affiliation>
</author>
<author><persName><forename type="first">Alexis</forename>
<surname>Brice</surname>
</persName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
</author>
</analytic>
<monogr><title level="j">Human Molecular Genetics</title>
<title level="j" type="abbrev">Hum. Mol. Genet.</title>
<idno type="pISSN">0964-6906</idno>
<idno type="eISSN">1460-2083</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="2003-06-15"></date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1427">1427</biblScope>
<biblScope unit="page" to="1437">1437</biblScope>
</imprint>
</monogr>
<idno type="istex">14FE1C249A46B8793718122C5118CC5E1322F317</idno>
<idno type="DOI">10.1093/hmg/ddg159</idno>
<idno type="local">ddg159</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2003</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. Mutations in the parkin gene, which encodes an E3 ubiquitin–protein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.</p>
</abstract>
</profileDesc>
<revisionDesc><change when="2003-06-15">Published</change>
<change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-15">References added</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="corpus oup" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="US-ASCII"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType>
<istex:document><article xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="hwp">hmg</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title>Human Molecular Genetics</journal-title>
<abbrev-journal-title abbrev-type="publisher">Hum. Mol. Genet.</abbrev-journal-title>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher><publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="other">ddg159</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddg159</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Corti</surname>
<given-names>Olga</given-names>
</name>
<xref rid="AF1">1</xref>
<xref rid="FN2">†</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Hampe</surname>
<given-names>Cornelia</given-names>
</name>
<xref rid="AF1">1</xref>
<xref rid="FN2">†</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Koutnikova</surname>
<given-names>Hana</given-names>
</name>
<xref rid="AF1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Darios</surname>
<given-names>Frédéric</given-names>
</name>
<xref rid="AF1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Jacquier</surname>
<given-names>Sandrine</given-names>
</name>
<xref rid="AF1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Prigent</surname>
<given-names>Annick</given-names>
</name>
<xref rid="AF1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Robinson</surname>
<given-names>Jean-Charles</given-names>
</name>
<xref rid="AF2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Pradier</surname>
<given-names>Laurent</given-names>
</name>
<xref rid="AF3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ruberg</surname>
<given-names>Merle</given-names>
</name>
<xref rid="AF1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mirande</surname>
<given-names>Marc</given-names>
</name>
<xref rid="AF2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Hirsch</surname>
<given-names>Etienne</given-names>
</name>
<xref rid="AF1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rooney</surname>
<given-names>Thomas</given-names>
</name>
<xref rid="AF3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Fournier</surname>
<given-names>Alain</given-names>
</name>
<xref rid="AF3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Brice</surname>
<given-names>Alexis</given-names>
</name>
<xref rid="AF1">1</xref>
<xref rid="FN1">*</xref>
</contrib>
<aff id="AF1"><sup>1</sup>
INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</aff>
<aff id="AF2"><sup>2</sup>
Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</aff>
<aff id="AF3"><sup>3</sup>
CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</aff>
</contrib-group>
<pub-date pub-type="ppub"><day>15</day>
<month>06</month>
<year>2003</year>
</pub-date>
<volume>12</volume>
<issue>12</issue>
<fpage>1427</fpage>
<lpage>1437</lpage>
<history><date date-type="accepted"><day>22</day>
<month>04</month>
<year>2003</year>
</date>
<date date-type="received"><day>22</day>
<month>01</month>
<year>2003</year>
</date>
<date date-type="rev-recd"><day>04</day>
<month>04</month>
<year>2003</year>
</date>
</history>
<permissions><copyright-year>2003</copyright-year>
</permissions>
<abstract xml:lang="en"><p>Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. Mutations in the <italic>parkin</italic>
 gene, which encodes an E3 ubiquitin–protein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in <italic>parkin</italic>
-related parkinsonism. Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.</p>
</abstract>
<custom-meta-wrap><custom-meta><meta-name>hwp-legacy-fpage</meta-name>
<meta-value>1427</meta-value>
</custom-meta>
<custom-meta><meta-name>hwp-legacy-dochead</meta-name>
<meta-value>Article</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA"><title>The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration</title>
</titleInfo>
<name type="personal"><namePart type="given">Olga</namePart>
<namePart type="family">Corti</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Cornelia</namePart>
<namePart type="family">Hampe</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Hana</namePart>
<namePart type="family">Koutnikova</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Frédéric</namePart>
<namePart type="family">Darios</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Sandrine</namePart>
<namePart type="family">Jacquier</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Annick</namePart>
<namePart type="family">Prigent</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Jean-Charles</namePart>
<namePart type="family">Robinson</namePart>
<affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Laurent</namePart>
<namePart type="family">Pradier</namePart>
<affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Merle</namePart>
<namePart type="family">Ruberg</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Marc</namePart>
<namePart type="family">Mirande</namePart>
<affiliation>Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Etienne</namePart>
<namePart type="family">Hirsch</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Thomas</namePart>
<namePart type="family">Rooney</namePart>
<affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Alain</namePart>
<namePart type="family">Fournier</namePart>
<affiliation>CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Alexis</namePart>
<namePart type="family">Brice</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Bâtiment Pharmacie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France,</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article"></genre>
<originInfo><publisher>Oxford University Press</publisher>
<dateIssued encoding="w3cdtf">2003-06-15</dateIssued>
<copyrightDate encoding="w3cdtf">2003</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. Mutations in the parkin gene, which encodes an E3 ubiquitin–protein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.</abstract>
<relatedItem type="host"><titleInfo><title>Human Molecular Genetics</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Hum. Mol. Genet.</title>
</titleInfo>
<genre type="Journal">journal</genre>
<identifier type="ISSN">0964-6906</identifier>
<identifier type="eISSN">1460-2083</identifier>
<identifier type="PublisherID">hmg</identifier>
<identifier type="PublisherID-hwp">hmg</identifier>
<identifier type="PublisherID-nlm-ta">Hum Mol Genet</identifier>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>12</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>1427</start>
<end>1437</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">14FE1C249A46B8793718122C5118CC5E1322F317</identifier>
<identifier type="DOI">10.1093/hmg/ddg159</identifier>
<identifier type="local">ddg159</identifier>
<recordInfo><recordContentSource>OUP</recordContentSource>
</recordInfo>
</mods>
</metadata>
<annexes><json:item><original>true</original>
<mimetype>image/jpeg</mimetype>
<extension>jpeg</extension>
<uri>https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/annexes/jpeg</uri>
</json:item>
<json:item><original>true</original>
<mimetype>image/gif</mimetype>
<extension>gif</extension>
<uri>https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/annexes/gif</uri>
</json:item>
</annexes>
<enrichments><istex:catWosTEI uri="https://api.istex.fr/document/14FE1C249A46B8793718122C5118CC5E1322F317/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">BIOCHEMISTRY & MOLECULAR BIOLOGY</classCode>
<classCode scheme="WOS">GENETICS & HEREDITY</classCode>
</textClass>
</profileDesc>
</teiHeader>
</istex:catWosTEI>
</enrichments>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A90 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002A90 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:14FE1C249A46B8793718122C5118CC5E1322F317
   |texte=   The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024

	Serveur d'exploration sur la maladie de Parkinson
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la maladie de Parkinson

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri